EXEL
Exelixis, Inc. · Healthcare
CSO, EVP Disc, Trans Research Dana Aftab sold $2.4M of Exelixis, Inc.
Sold$2,375,000
$25.00Price
95,000Shares
−15%Stake
What EXEL did after the filing
- The stock from Fri, Aug 9 close, $26.97
- −2.3%
- S&P 500, same days
- +7.2%
Measured over 30 trading days, to the Sep 23 close.
Traded Wed, Aug 7. Filed Fri, Aug 9, 3:32 PM ET, during the session. Returns use the Aug 9 close and the Sep 23 close. Not investment advice.